Variant report
Variant | nsv817984 |
---|---|
Chromosome Location | chr2:57842075-57845016 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:57835362..57837031-chr2:57842743..57844296,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10172608 | chr2:57842075-57842076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs529936346 | chr2:57842076-57842077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547811187 | chr2:57842108-57842109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549723221 | chr2:57842158-57842159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563444331 | chr2:57842213-57842214 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560461519 | chr2:57842218-57842219 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532248249 | chr2:57842228-57842229 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552262441 | chr2:57842240-57842241 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565716496 | chr2:57842252-57842253 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192016471 | chr2:57842254-57842255 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548096007 | chr2:57842258-57842259 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529231509 | chr2:57842262-57842263 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567847000 | chr2:57842264-57842265 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569659747 | chr2:57842284-57842285 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149166797 | chr2:57842315-57842316 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558158088 | chr2:57842329-57842330 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556344457 | chr2:57842342-57842343 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569877339 | chr2:57842393-57842394 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548620341 | chr2:57842422-57842423 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538791267 | chr2:57842430-57842431 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17810870 | chr2:57842453-57842454 | Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs572433665 | chr2:57842456-57842457 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541052460 | chr2:57842458-57842459 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554913818 | chr2:57842459-57842460 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574665245 | chr2:57842500-57842501 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143524991 | chr2:57842522-57842523 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184666075 | chr2:57842534-57842535 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563481924 | chr2:57842543-57842544 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148032601 | chr2:57842552-57842553 | Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545964693 | chr2:57842606-57842607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11898116 | chr2:57842611-57842612 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs13030457 | chr2:57842655-57842656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200287532 | chr2:57842657-57842658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528121463 | chr2:57842680-57842681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547900456 | chr2:57842743-57842744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10173141 | chr2:57842770-57842771 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs530338922 | chr2:57842807-57842808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533541729 | chr2:57842883-57842884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188683333 | chr2:57842884-57842885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569962613 | chr2:57842886-57842887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114336995 | chr2:57842938-57842939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566947723 | chr2:57842948-57842949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558663289 | chr2:57842953-57842954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566058991 | chr2:57842954-57842955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535088030 | chr2:57842982-57842983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10196912 | chr2:57843046-57843047 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs574732881 | chr2:57843049-57843050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543777154 | chr2:57843078-57843079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10199287 | chr2:57843117-57843118 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs554193694 | chr2:57843135-57843136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57828000-57842200 | Weak transcription | Thymus | Thymus |
2 | chr2:57842200-57842400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr2:57842200-57842600 | Genic enhancers | Thymus | Thymus |
4 | chr2:57842200-57842800 | Enhancers | Fetal Thymus | thymus |
5 | chr2:57842600-57843400 | Enhancers | Thymus | Thymus |
6 | chr2:57842800-57843200 | Weak transcription | Fetal Thymus | thymus |
7 | chr2:57842800-57844200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr2:57843200-57843400 | Enhancers | Fetal Thymus | thymus |
9 | chr2:57843400-57843800 | Enhancers | Fetal Heart | heart |
10 | chr2:57843400-57844400 | Weak transcription | Fetal Thymus | thymus |
11 | chr2:57843400-57844400 | Weak transcription | Thymus | Thymus |
12 | chr2:57844200-57845000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr2:57844400-57844600 | Flanking Active TSS | Fetal Thymus | thymus |
14 | chr2:57844400-57844600 | Flanking Active TSS | Thymus | Thymus |
15 | chr2:57844400-57844800 | Enhancers | Primary B cells from peripheral blood | blood |
16 | chr2:57844400-57844800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr2:57844600-57846400 | Active TSS | Fetal Thymus | thymus |
18 | chr2:57844600-57846400 | Active TSS | Thymus | Thymus |